| Application no. and date | 00304611.7 (espacenet) (Federated) (European Patent Register), 20000530 | | Patent/reg. no. and date | DK/EP 1057480, 20040623 | | Publication date | 20001206 | | Priority no. and date | US 137164 P, 19990601 | | EP pub. no. and date |
EP 1057480 20001206 | | Effective date | | | Applicant/owner | Pfizer Products Inc., Eastern Point Road
Groton,
Connecticut 06340, US | | Applicant ref. no. | P200400953 EP DK | | Inventor | Da Silva-Jardine, Paul Andrew, Pfizer Central Research,
Eastern Point Road
Groton,
Connecticut 06340, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/40, A61K 31/439, A61K 31/445, A61P 5/32, A61K 9/70 | | Title | Transdermal østrogen-agonist-antagonist-behandling | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
